Find uplifting stories about heroes, innovations, and solutions
4 results for "hunter syndrome"
Families affected by Hunter syndrome now have hope as the FDA approves Avlayah, the first treatment designed to replace a missing enzyme that causes dangerous sugar buildup in the brain. This breakthrough marks a major victory for patients with this rare genetic disease.
The FDA just approved Denali Therapeutics' new medicine for Hunter syndrome, bringing fresh hope to families affected by this rare genetic disease. The approval comes as a welcome surprise after the agency recently toughened its standards for rare disease treatments.
Children with Hunter syndrome just got their first new treatment option in nearly two decades. The FDA approved AVLAYAH, a breakthrough therapy from Denali Therapeutics that offers fresh hope to families facing this rare genetic disease.
Children with a rare genetic disorder are developing normally thanks to an enzyme therapy crossing the blood-brain barrier. The FDA could approve the treatment this spring, offering hope to families worldwide.